{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:48:00Z","timestamp":1768081680326,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National key research and development project of China","award":["2016YFA0502003"],"award-info":[{"award-number":["2016YFA0502003"]}]},{"name":"Shanghai Jiao Tong University School of Medicine and Shanghai SJTUSM Biobank","award":["15ZH4006"],"award-info":[{"award-number":["15ZH4006"]}]}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.numecd.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T18:52:10Z","timestamp":1508352730000},"page":"119-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status"],"prefix":"10.1016","volume":"28","author":[{"given":"X.","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2017.10.009_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2017.10.009_bib2","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/eurheartj\/ehv509","article-title":"Obesity and cardiovascular disease: friend or foe?","volume":"37","author":"Kim","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.10.009_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.numecd.2017.10.009_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/en.2012-1891","article-title":"Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats","volume":"154","author":"Ryan","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2017.10.009_bib5","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2017.10.009_bib6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/endo.143.5.8850","article-title":"Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity","volume":"143","author":"Tomlinson","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.numecd.2017.10.009_bib7","doi-asserted-by":"crossref","first-page":"e38438","DOI":"10.1371\/journal.pone.0038438","article-title":"Fundamentals of FGF19 & FGF21 action in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Adams","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2017.10.009_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.numecd.2017.10.009_bib9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"G\u00f3mez-Ambrosi","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2017.10.009_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.33549\/physiolres.932099","article-title":"Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-\u03b1 agonist treatment","volume":"60","author":"Mr\u00e1z","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.numecd.2017.10.009_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients","volume":"39","author":"Gallego-Escuredo","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.numecd.2017.10.009_bib12","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.2337\/dc12-1766","article-title":"Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels","volume":"36","author":"Fang","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2017.10.009_bib13","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/dc10-0120","article-title":"Associations of visceral and subcutaneous fat areas with the prevalence of metabolic risk factor clustering in 6,292 Japanese individuals: the Hitachi Health Study","volume":"33","author":"Matsushita","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2017.10.009_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jc.2012-2906","article-title":"Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men","volume":"98","author":"Bao","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2017.10.009_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2017.10.009_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.diabres.2005.10.005","article-title":"Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT","volume":"72","author":"Tura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2017.10.009_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oralglucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2017.10.009_bib18","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complication. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus","author":"World Health Organization. Department of Noncommunicable Disease Surveillance","year":"1999"},{"key":"10.1016\/j.numecd.2017.10.009_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JOE-16-0206","article-title":"Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus","volume":"231","author":"Kav\u00e1lkov\u00e1","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.numecd.2017.10.009_bib20","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00125-013-3002-1","article-title":"Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research","volume":"56","author":"Wagner","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2017.10.009_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/ijo.2016.147","article-title":"Contribution of a first-degree family history of diabetes to increased serum adipocyte fatty acid binding protein levels independent of body fat content and distribution","volume":"40","author":"Hu","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.numecd.2017.10.009_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lundasen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2017.10.009_bib23","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2337\/dc06-0438","article-title":"Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans","volume":"29","author":"Meyer","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2017.10.009_bib24","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317302363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317302363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:20:45Z","timestamp":1603164045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475317302363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0939475317302363"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2017.10.009","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of serum fibroblast growth factor 19 levels with visceral fat accumulation is independent of glucose tolerance status","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}